Henry R. Charlton

Henry R. Charlton, Pall Corporation - Qepler Summits And Conferences

Henry R. Charlton

Global Marketing Director – Medical OEM
Pall Corporation
London, United Kingdom
Pall Medical filtration solutions can help improve quality, while reducing costs. We’re able to help large and small organizations, providing the opportunity to scale operations up or down as needed. Let our expertise guide you through these unchartered waters, so you can get back to doing what you do best and let us take care of the rest.

Bachelors in Biological Sciences, Masters in Biochemical Engineering from University College London and PhD studies on the Characterisation of Harvesting Procedures for Monoclonal Antibodies.

Experience of biopharmaceutical development and now acts as Director of Marketing for Pall Medical’s OEM business.

Related Sessions:

Qepler - Drug/Device Combination Products Summit thumbnail Details

Drug/Device Combination
Products Summit 2018

Get up to date with the regulatory and quality compliance strategies for combination product development.
  • 04 Dec 2018
  • Berlin, DE
  • Pharma
Day 2: Wednesday, 05 December 2018
BLOCK: SAFETY EVALUATION AND CHEMICAL CHARACTERISATION.
CASE STUDY: A case study of large-volume device manufacture using a bi-functional membrane.
  • Introduction to Pall Medical
  • A case study of large-volume device manufacture
  • Opinion from technical, scientific and commercial perspectives on clinical point-of-use filtration
  • Risks associated with clinical point of use filtration
  • Where does filtration fit into delivery devices?
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.